| Gene symbol | HSPB1 | Synonyms | CMT2F, HEL-S-102, HMN2B, HMND3, HS.76067, HSP27, HSP28, Hsp25, SRP27 | Type of gene | protein-coding |
| Chromosome | 7 | Map location | 7q11.23 | dbXrefs | |
| Description | heat shock protein family B (small) member 1 | ||||
| GTO ID | GTC0163 |
| Trial ID | NCT01829113 |
| Disease | Lung Non-Squamous Non-Small Cell Carcinoma |
| Altered gene | Hsp27 |
| Therapeutic/Target gene | Target gene |
| Therapy | ASO |
| Treatment | OGX-427|Apatorsen |
| Phase | Phase2 |
| Recruitment status | Completed |
| Title | Double-Blind Randomized Phase II Trial of Carboplatin and Pemetrexed With or Without OGX-427 in Patients With Previously Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer (The Spruce Clinical Trial) |
| Year | 2013 |
| Country | United States |
| Company sponsor | SCRI Development Innovations, LLC |
| Other ID(s) | SCRI LUN 229 |
| Vector information | |||
|
|||
| Cohort 1 | |||||||||||
|
|||||||||||